Your session is about to expire
← Back to Search
NR Supplementation + Exercise for Cancer Survivors (IAMFIT Trial)
IAMFIT Trial Summary
This trial will test the effects of an NAD+ precursor and exercise on skeletal muscle quality and VO2max in AYA HCT survivors. The primary outcome is the change in muscle strength from baseline to 16 weeks.
IAMFIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIAMFIT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IAMFIT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe symptoms from a narrowed heart valve.I am pregnant or planning to become pregnant.I do not have any health conditions that worsen with exercise.I take insulin or medication to increase insulin for my diabetes.I cannot do exercise tests or training due to physical limitations.My liver enzymes are not more than three times the upper limit.I have had blood clots in my legs.I haven't taken high doses of NAD+ boosters in the last 4 weeks.I am between 10 and 30 years old.I weigh at least 24 kg.I am not taking medications that increase the risk of nerve damage.My kidney function is reduced.I have not had a recent heart attack or unstable chest pain.I have moderate or severe asthma as shown by my lung function tests.I am not pregnant and will use birth control during the study.I haven't taken experimental drugs or high-dose steroids in the last 4 weeks.I have experienced fainting spells more than once.I have leukemia, aplastic anemia, or myelodysplastic syndrome and need a bone marrow transplant.I had a stem cell transplant from a donor between 6 to 48 months ago.I have a heart rhythm problem that causes symptoms and is not under control.I have not had a pulmonary embolus in the last 3 months.
- Group 1: Nicotinamide Riboside (NR)
- Group 2: Placebo
- Group 3: Exercise Intervention and NR
- Group 4: Exercise Intervention and Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are we looking for more participants in this clinical trial at the moment?
"The trial, as per the information available on clinicaltrials.gov, is ongoing and looking for participants. The posting date was November 18th, 2022 with the most recent update occurring on November 3rd of the same year."
How often do patients report negative side effects from the Exercise Intervention program?
"While there is evidence that the Exercise Intervention is safe, it only received a score of 2 because, at this stage in clinical trials, efficacy has not been statistically supported."
Which patients would be the best candidates for this clinical trial?
"This leukemia clinical trial is only considering patients that are in remission and between the ages of 10-30. Out of the 80 total people they are hoping to enroll,"
Does this research project require participants to be over a certain age?
"This study is seeking participants that are aged 10-30."
Share this study with friends
Copy Link
Messenger